Xylem (XYL) | Financial Analysis & Statements
Xylem Inc. Large-cap Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
2.4B
Gross Profit
932.0M
38.88%
Operating Income
386.0M
16.10%
Net Income
333.0M
13.89%
Balance Sheet Metrics
Total Assets
17.6B
Total Liabilities
5.9B
Shareholders Equity
11.7B
Debt to Equity
0.50
Cash Flow Metrics
Operating Cash Flow
676.0M
Free Cash Flow
460.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Xylem Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9.0B | 8.6B | 7.4B | 5.5B | 5.2B |
| Cost of Goods Sold | 5.6B | 5.4B | 4.6B | 3.4B | 3.2B |
| Gross Profit | 3.5B | 3.2B | 2.7B | 2.1B | 2.0B |
| Gross Margin % | 38.5% | 37.5% | 36.9% | 37.7% | 38.0% |
| Operating Expenses | |||||
| Research & Development | 226.0M | 230.0M | 232.0M | 206.0M | 204.0M |
| Selling, General & Administrative | 1.9B | 1.9B | 1.8B | 1.4B | 1.2B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 2.1B | 2.1B | 2.0B | 1.6B | 1.4B |
| Operating Income | 1.3B | 1.1B | 728.0M | 511.0M | 592.0M |
| Operating Margin % | 14.7% | 12.5% | 9.9% | 9.3% | 11.4% |
| Non-Operating Items | |||||
| Interest Income | 27.0M | 28.0M | 28.0M | 16.0M | 7.0M |
| Interest Expense | 29.0M | 44.0M | 49.0M | 50.0M | 76.0M |
| Other Non-Operating Income | -143.0M | 32.0M | -72.0M | -37.0M | -12.0M |
| Pre-tax Income | 1.2B | 1.1B | 635.0M | 440.0M | 511.0M |
| Income Tax | 231.0M | 197.0M | 26.0M | 85.0M | 84.0M |
| Effective Tax Rate % | 19.6% | 18.1% | 4.1% | 19.3% | 16.4% |
| Net Income | 950.0M | 890.0M | 609.0M | 355.0M | 427.0M |
| Net Margin % | 10.5% | 10.4% | 8.3% | 6.4% | 8.2% |
| Key Metrics | |||||
| EBITDA | 1.9B | 1.8B | 1.2B | 754.0M | 837.0M |
| EPS (Basic) | $3.93 | $3.67 | $2.81 | $1.97 | $2.37 |
| EPS (Diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 |
| Basic Shares Outstanding | 243400000 | 242600000 | 217000000 | 180200000 | 180200000 |
| Diluted Shares Outstanding | 243400000 | 242600000 | 217000000 | 180200000 | 180200000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Xylem Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.5B | 1.1B | 1.0B | 944.0M | 1.3B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 1.8B | 1.7B | 1.6B | 1.1B | 953.0M |
| Inventory | 983.0M | 996.0M | 1.0B | 799.0M | 700.0M |
| Other Current Assets | 244.0M | 236.0M | 230.0M | 173.0M | 158.0M |
| Total Current Assets | 4.6B | 4.1B | 3.9B | 3.0B | 3.2B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 931.0M | 866.0M | 983.0M | 661.0M | 651.0M |
| Goodwill | 18.9B | 18.3B | 17.7B | 6.4B | 6.6B |
| Intangible Assets | 2.3B | 2.4B | 2.5B | 930.0M | 1.0B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.2B | 884.0M | 943.0M | 661.0M | 664.0M |
| Total Non-Current Assets | 13.0B | 12.4B | 12.2B | 4.9B | 5.1B |
| Total Assets | 17.6B | 16.5B | 16.1B | 8.0B | 8.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.0B | 1.0B | 968.0M | 723.0M | 639.0M |
| Short-term Debt | 655.0M | 147.0M | 122.0M | 69.0M | 69.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 72.0M | 21.0M | - | - | - |
| Total Current Liabilities | 2.9B | 2.3B | 2.2B | 1.6B | 1.4B |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.4B | 2.0B | 2.3B | 1.9B | 2.4B |
| Deferred Tax Liabilities | 405.0M | 497.0M | 557.0M | 222.0M | 287.0M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 3.0B | 3.3B | 3.7B | 2.9B | 3.7B |
| Total Liabilities | 5.9B | 5.6B | 5.9B | 4.4B | 5.0B |
| Equity | |||||
| Common Stock | 3.0M | 3.0M | 3.0M | 2.0M | 2.0M |
| Retained Earnings | 3.7B | 3.1B | 2.6B | 2.3B | 2.2B |
| Treasury Stock | 768.0M | 753.0M | 733.0M | 708.0M | 656.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 11.7B | 10.9B | 10.2B | 3.5B | 3.2B |
| Key Metrics | |||||
| Total Debt | 2.1B | 2.1B | 2.4B | 1.9B | 2.5B |
| Working Capital | 1.8B | 1.8B | 1.7B | 1.4B | 1.8B |
Balance Sheet Composition
Xylem Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 950.0M | 890.0M | 609.0M | 355.0M | 427.0M |
| Depreciation & Amortization | 575.0M | 562.0M | 436.0M | 236.0M | 245.0M |
| Stock-Based Compensation | 53.0M | 56.0M | 60.0M | 37.0M | 33.0M |
| Working Capital Changes | -264.0M | -143.0M | -98.0M | -216.0M | -134.0M |
| Operating Cash Flow | 1.3B | 1.3B | 949.0M | 343.0M | 542.0M |
| Investing Activities | |||||
| Capital Expenditures | 17.0M | 4.0M | 1.0M | 4.0M | 3.0M |
| Acquisitions | -114.0M | -188.0M | -428.0M | -2.0M | 5.0M |
| Investment Purchases | -49.0M | -11.0M | -1.0M | -21.0M | 0 |
| Investment Sales | 43.0M | 35.0M | 67.0M | 33.0M | 14.0M |
| Investing Cash Flow | -140.0M | -161.0M | -357.0M | 17.0M | 25.0M |
| Financing Activities | |||||
| Share Repurchases | -15.0M | -20.0M | -25.0M | -52.0M | -68.0M |
| Dividends Paid | -391.0M | -350.0M | -299.0M | -217.0M | -203.0M |
| Debt Issuance | 0 | 1.0M | 278.0M | 0 | 0 |
| Debt Repayment | -82.0M | -285.0M | -160.0M | -527.0M | -600.0M |
| Financing Cash Flow | -521.0M | -950.0M | -219.0M | -798.0M | -874.0M |
| Free Cash Flow | 910.0M | 942.0M | 566.0M | 388.0M | 330.0M |
| Net Change in Cash | 618.0M | 227.0M | 373.0M | -438.0M | -307.0M |
Cash Flow Trend
Xylem Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.98
Forward P/E
20.03
Price to Book
2.58
Price to Sales
3.27
PEG Ratio
20.03
Profitability Ratios
Profit Margin
10.59%
Operating Margin
15.98%
Return on Equity
8.40%
Return on Assets
4.83%
Financial Health
Current Ratio
1.62
Debt to Equity
21.07
Beta
1.17
Per Share Data
EPS (TTM)
$3.92
Book Value per Share
$47.13
Revenue per Share
$37.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| XYL | 29.6B | 30.98 | 2.58 | 8.40% | 10.59% | 21.07 |
| GE Vernova | 308.9B | 33.64 | 27.72 | 75.71% | 23.81% | 18.63 |
| Eaton | 164.9B | 39.53 | 8.25 | 21.53% | 14.89% | 54.88 |
| Parker Hannifin | 122.9B | 35.46 | 8.58 | 25.78% | 17.29% | 68.93 |
| Cummins | 91.4B | 32.05 | 7.35 | 23.93% | 8.44% | 60.52 |
| Emerson Electric | 80.1B | 35.50 | 4.01 | 9.65% | 12.72% | 69.28 |
Financial data is updated regularly. All figures are in the company's reporting currency.






